Jiwen Chen, Ashok Dongre. . Improving the Pharmaceutical Properties of Biologics in Drug Discovery: Unique Challenges and Enabling Solutions. 2012:, 67-77. /JiwenChen, AshokDongre. Improving the Pharmaceutical Properties of Biologics in Drug Discovery: Unique Challenges and Enabling Solutions. 2012:,...
Working alongside a supportive partner can help ensure a cell line strategy is effective and can aid in maintaining tight timelines. Experienced contract development and manufacturing organizations (CDMOs) have the expertise to help overcome the challenges often encountered at this early st...
Our teams, backed by 50+ years of experience and a proven track record of excellence, optimize, adapt, and perfect innovative technologies and drug substance development approaches to deliver world-class solutions for pharmaceutical manufacturing. We thrive on the vexing challenges few CDMOs would hav...
in the project, guided by the right analytical methods, resulted in a remarkable 3.4-fold overall increase in productivity. This case study underscores the effectiveness of end-to-end collaboration, showcasing the ability to overcome challenges, achieve higher productivity, and meet client expectat...
Research, Development, & Manufacturing of Biologics A Process With Many Challenges With the growing demand for biologics to treat and prevent human disease, including vaccines, cell and gene therapies, mAbs, and biosimilars1-3, manufacturers who can quickly deliver safe and effective products will be...
REVIEWS Challenges and approaches for the development of safer immunomodulatory biologics Jean G. Sathish1*, Swaminathan Sethu1*, Marie-Christine Bielsky2, Lolke de Haan3, Neil S. French1, Karthik Govindappa1, James Green4, Christopher E. M. Griffiths5, Stephen Holgate6, David Jones2...
Key challenges faced at each stage of mAb development and provides guidance for streamlining pipeline progress of therapeutic mAb candidates Download Whitepaper Infographic Five Ways to Get to IND/ IMPD Faster Download infographic Biologics CDMO Solutions and Capabilities Process development and validati...
BOSE M, FARIAS QUIPILDOR G, EHRLICH M E, et al.Intranasal peptide therapeutics:A promising avenue for overcoming the challenges of traditional CNS drug development[J].Cells, 2022, 11(22):3629. [2] AGRAWAL M, SARAF S, SARAF S, et al.Nose-to-brain drug delivery:An update on clinical...
center on biologics drug development starting from cell line generation, process, analytical and formulation development to GMP production. The technical and regulatory know-how at STC Biologics enables integrated product development planning and successful maneuvering through inevitable development challenges. ...
An overview of drug development in the United States and current challenges. Drug development in the United States has undergone many changes in the past 25 years, but relatively few fully realize the complexities involved in develo... Moore,S Wyatt - 《Southern Medical Journal》 被引量: 28发...